Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rheumatoid arthritis
rheumatoid arthritis
AstraZeneca's RA Drug Disappoints
Yahoo/Zacks
Sat, 12/15/12 - 12:43 pm
AstraZeneca
rheumatoid arthritis
fostamatinib
Rigel Pharmaceuticals
Lilly stops rheumatoid arthritis trial for lack of efficacy
Reuters
Thu, 12/13/12 - 11:38 am
Eli Lilly
tabalumab
rheumatoid arthritis
Hopes fade for AstraZeneca and Rigel's arthritis pill
Reuters
Thu, 12/13/12 - 11:05 am
Rigel
AstraZeneca
fostamatinib
Humira
Abbott Labs
rheumatoid arthritis
Unlocking Antares' Vision For Arthritis Patients
Seeking Alpha
Mon, 12/10/12 - 10:52 am
Antares
rheumatoid arthritis
Horizon Pharma begins initial commercial launch of Rayos in the U.S.
The Fly on the Wall
Mon, 12/3/12 - 10:24 am
Rayos
Horizon Pharma
rheumatoid arthritis
Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis
Yahoo
Thu, 11/15/12 - 11:06 am
baricitinib
Incyte
JAK inhibitors
Eli Lilly
rheumatoid arthritis
Lilly arthritis drug shows durability in study
Reuters
Tue, 11/13/12 - 05:36 pm
Eli Lilly
baricitinib
Incyte
rheumatoid arthritis
Horizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis
Yahoo/MarketWire
Sun, 11/11/12 - 09:34 am
Horizon Therapeutics
Rayos
rheumatoid arthritis
Hot Off the Press: Pfizer Goes After Abbott
Motley Fool
Wed, 11/7/12 - 11:40 am
Abbott Labs
Pfizer
Xeljanz
tofacitnib
rheumatoid arthritis
Pfizer's Future May Hinge On Tofacitinib FDA Action In November
Seeking Alpha
Thu, 11/1/12 - 06:06 pm
FDA
Pfizer
tofacitinib
rheumatoid arthritis
Could Tofacitinib Save Pfizer?
Seeking Alpha
Tue, 10/23/12 - 04:20 pm
tofacitinib
Pfizer
JNJ
Eli Lilly
rheumatoid arthritis
Roche Faces New Foe as Boehringer Plans a Rituxan Copy
Bloomberg
Fri, 10/5/12 - 11:27 am
Roche
Rituxan
Boehringer Ingelheim
rheumatoid arthritis
J&J and Astellas Collaborate
Yahoo/Zacks
Thu, 10/4/12 - 10:42 am
JNJ
Astellas
JAK inhibitors
ASP015K
rheumatoid arthritis
MorphoSys Chief Says MOR103 Drug Data Makes Deal More Likely
Bloomberg
Fri, 09/21/12 - 11:35 am
MorphoSys
MOR103
rheumatoid arthritis
Pfizer study shows tofacitinib monotherapy superior to methotrexate
Yahoo/Fly on the Wall
Mon, 09/17/12 - 03:46 pm
Pfizer
rheumatoid arthritis
tofacitinib
"Better Than Nothing" Doesn't Cut It for Zalicus
Motley Fool
Tue, 09/11/12 - 10:46 am
Zalicus
Synavive
rheumatoid arthritis
Zalicus Misses Key Secondary Endpoint
Seeking Alpha
Mon, 09/10/12 - 01:40 pm
Zalicus
Amgen
Novartis
Sanofi
Synavive
rheumatoid arthritis
Is Tofacitinib One Of Pfizer's New Cash Cows?
Seeking Alpha
Fri, 09/7/12 - 09:00 am
Pfizer
tofacitinib
JNJ
Abbott Labs
rheumatoid arthritis
Rigel Pharma: Key RA Drug Data Expected Late 2012 Through H1 2013
Seeking Alpha
Tue, 09/4/12 - 12:22 pm
Rigel Pharmaceuticals
rheumatoid arthritis
fostamatinib
Do We Really Need Another Injected Rheumatoid Arthritis Drug?
Motley Fool
Sat, 08/25/12 - 12:04 pm
rheumatoid arthritis
sirukumab
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »